All In Biotech

Drug Trial Radar · NCT01336153

Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke

Last checked: Nov 19, 2026Latest source record: May 2, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

Aug 2009

Primary completion

Jan 2010

Study completion Dec 2010

Sponsor

Lead sponsor
Shahid Beheshti UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Shahid Beheshti University of Medical Sciences
First posted
Apr 15, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 30 years, up to 72 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To investigate the safety and efficacy of MLC601 (NeuroAideTM) as a Traditional Chinese Medicine on motor recovery after ischemic stroke.

Conditions

  • Stroke

Interventions

  • MLC601Drug

    group A (100 patients; NeuroAid 400mg, 4 capsules 3 times daily) or for 3 month

  • PlaceboDrug

    group B (50 patients; placebo, 4 capsules 3 times daily) for 3 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigate the Safety and Efficacy of MLC601Time frame: 18 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.